Lupus Research Alliance Applauds U.S. FDA Breakthrough Therapy Designation for Litifilimab in Cutaneous Lupus Erythematosus
Decision Could Speed Up Treatment Approval for Skin-Related Lupus Manifestation The Lupus Research Alliance applauds the decision by the U.S. Food...